Schistosomiasis Market 2027 by Site, Drug Type and Geography | The Insight Partners

Schistosomiasis Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Site (Intestinal, Urogenital); Drug Type (Praziquantel, Metrifonate, Oxamniquine) and Geography

Report Code: TIPRE00008459 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Schistosomiasis is an acute and chronic disease caused by parasitic worms. According to, WHO Estimates it shows that at least 220.8 million people required preventive treatment for schistosomiasis in 2017, out of which more than 102.3 million people were reported to have been treated. There are 2 major forms of schistosomiasis intestinal and urogenital caused by 5 main species of blood fluke. Currently only three drugs are used on a global scale for the treatment of schistosomiasis: praziquantel, metrifonate, and oxamniquine.

MARKET DYNAMICS

The factors that drive the growth of the global drugs for schistosomiasis market include rise in prevalence of schistosomiasis, lack of safe drinking water and lack of hygiene in developing countries. However, lack of awareness about the treatment may restrain the market growth. Furthermore, strategic initiatives taken by healthcare authorities, such as WHO, which is working with partners and the private sector and has sponsored for increased access to praziquantel and resources for implementation are anticipated to offer lucrative opportunities it the forecast period.

MARKET SCOPE

`
The "Global Drugs for Schistosomiasis Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Drugs for Schistosomiasis Market with detailed market segmentation by site, drug type and geography. The Global Drugs for Schistosomiasis Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Drugs for Schistosomiasis Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Drugs for Schistosomiasis Market is segmented on the basis of site and drug type. On the basis of site, the market is segmented into intestinal and urogenital. On the basis of drug type the market is segmented into praziquantel, metrifonate, and oxamniquine ?


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drugs for Schistosomiasis Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drugs for Schistosomiasis Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Drugs for Schistosomiasis market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drugs for Schistosomiasis Market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Drugs for Schistosomiasis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Drugs for Schistosomiasis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Drugs for Schistosomiasis Market in the global market. Below mentioned is the list of few companies engaged in the Drugs for Schistosomiasis Market.

The report also includes the profiles of key Drugs for Schistosomiasis Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Shin Poong Pharma.Co., Ltd.
- Merck & Co., Inc.
- Bayer AG

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drugs For Schistosomiasis Market - By Site
1.3.2 Drugs For Schistosomiasis Market - By Drug Type
1.3.3 Drugs For Schistosomiasis Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUGS FOR SCHISTOSOMIASIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUGS FOR SCHISTOSOMIASIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DRUGS FOR SCHISTOSOMIASIS MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUGS FOR SCHISTOSOMIASIS - GLOBAL MARKET OVERVIEW
6.2. DRUGS FOR SCHISTOSOMIASIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUGS FOR SCHISTOSOMIASIS MARKET - REVENUE AND FORECASTS TO 2027 - SITE
7.1. OVERVIEW
7.2. SITE MARKET FORECASTS AND ANALYSIS
7.3. INTESTINAL
7.3.1. Overview
7.3.2. Intestinal Market Forecast and Analysis
7.4. UROGENITAL
7.4.1. Overview
7.4.2. Urogenital Market Forecast and Analysis
8. DRUGS FOR SCHISTOSOMIASIS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. PRAZIQUANTEL
8.3.1. Overview
8.3.2. Praziquantel Market Forecast and Analysis
8.4. METRIFONATE
8.4.1. Overview
8.4.2. Metrifonate Market Forecast and Analysis
8.5. OXAMNIQUINE
8.5.1. Overview
8.5.2. Oxamniquine Market Forecast and Analysis
9. DRUGS FOR SCHISTOSOMIASIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Drugs For Schistosomiasis Market Overview
9.1.2 North America Drugs For Schistosomiasis Market Forecasts and Analysis
9.1.3 North America Drugs For Schistosomiasis Market Forecasts and Analysis - By Site
9.1.4 North America Drugs For Schistosomiasis Market Forecasts and Analysis - By Drug Type
9.1.5 North America Drugs For Schistosomiasis Market Forecasts and Analysis - By Countries
9.1.5.1 United States Drugs For Schistosomiasis Market
9.1.5.1.1 United States Drugs For Schistosomiasis Market by Site
9.1.5.1.2 United States Drugs For Schistosomiasis Market by Drug Type
9.1.5.2 Canada Drugs For Schistosomiasis Market
9.1.5.2.1 Canada Drugs For Schistosomiasis Market by Site
9.1.5.2.2 Canada Drugs For Schistosomiasis Market by Drug Type
9.1.5.3 Mexico Drugs For Schistosomiasis Market
9.1.5.3.1 Mexico Drugs For Schistosomiasis Market by Site
9.1.5.3.2 Mexico Drugs For Schistosomiasis Market by Drug Type
9.2. EUROPE
9.2.1 Europe Drugs For Schistosomiasis Market Overview
9.2.2 Europe Drugs For Schistosomiasis Market Forecasts and Analysis
9.2.3 Europe Drugs For Schistosomiasis Market Forecasts and Analysis - By Site
9.2.4 Europe Drugs For Schistosomiasis Market Forecasts and Analysis - By Drug Type
9.2.5 Europe Drugs For Schistosomiasis Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Drugs For Schistosomiasis Market
9.2.5.1.1 Germany Drugs For Schistosomiasis Market by Site
9.2.5.1.2 Germany Drugs For Schistosomiasis Market by Drug Type
9.2.5.2 France Drugs For Schistosomiasis Market
9.2.5.2.1 France Drugs For Schistosomiasis Market by Site
9.2.5.2.2 France Drugs For Schistosomiasis Market by Drug Type
9.2.5.3 Italy Drugs For Schistosomiasis Market
9.2.5.3.1 Italy Drugs For Schistosomiasis Market by Site
9.2.5.3.2 Italy Drugs For Schistosomiasis Market by Drug Type
9.2.5.4 Spain Drugs For Schistosomiasis Market
9.2.5.4.1 Spain Drugs For Schistosomiasis Market by Site
9.2.5.4.2 Spain Drugs For Schistosomiasis Market by Drug Type
9.2.5.5 United Kingdom Drugs For Schistosomiasis Market
9.2.5.5.1 United Kingdom Drugs For Schistosomiasis Market by Site
9.2.5.5.2 United Kingdom Drugs For Schistosomiasis Market by Drug Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Drugs For Schistosomiasis Market Overview
9.3.2 Asia-Pacific Drugs For Schistosomiasis Market Forecasts and Analysis
9.3.3 Asia-Pacific Drugs For Schistosomiasis Market Forecasts and Analysis - By Site
9.3.4 Asia-Pacific Drugs For Schistosomiasis Market Forecasts and Analysis - By Drug Type
9.3.5 Asia-Pacific Drugs For Schistosomiasis Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Drugs For Schistosomiasis Market
9.3.5.1.1 Australia Drugs For Schistosomiasis Market by Site
9.3.5.1.2 Australia Drugs For Schistosomiasis Market by Drug Type
9.3.5.2 China Drugs For Schistosomiasis Market
9.3.5.2.1 China Drugs For Schistosomiasis Market by Site
9.3.5.2.2 China Drugs For Schistosomiasis Market by Drug Type
9.3.5.3 India Drugs For Schistosomiasis Market
9.3.5.3.1 India Drugs For Schistosomiasis Market by Site
9.3.5.3.2 India Drugs For Schistosomiasis Market by Drug Type
9.3.5.4 Japan Drugs For Schistosomiasis Market
9.3.5.4.1 Japan Drugs For Schistosomiasis Market by Site
9.3.5.4.2 Japan Drugs For Schistosomiasis Market by Drug Type
9.3.5.5 South Korea Drugs For Schistosomiasis Market
9.3.5.5.1 South Korea Drugs For Schistosomiasis Market by Site
9.3.5.5.2 South Korea Drugs For Schistosomiasis Market by Drug Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Drugs For Schistosomiasis Market Overview
9.4.2 Middle East and Africa Drugs For Schistosomiasis Market Forecasts and Analysis
9.4.3 Middle East and Africa Drugs For Schistosomiasis Market Forecasts and Analysis - By Site
9.4.4 Middle East and Africa Drugs For Schistosomiasis Market Forecasts and Analysis - By Drug Type
9.4.5 Middle East and Africa Drugs For Schistosomiasis Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Drugs For Schistosomiasis Market
9.4.5.1.1 South Africa Drugs For Schistosomiasis Market by Site
9.4.5.1.2 South Africa Drugs For Schistosomiasis Market by Drug Type
9.4.5.2 Saudi Arabia Drugs For Schistosomiasis Market
9.4.5.2.1 Saudi Arabia Drugs For Schistosomiasis Market by Site
9.4.5.2.2 Saudi Arabia Drugs For Schistosomiasis Market by Drug Type
9.4.5.3 U.A.E Drugs For Schistosomiasis Market
9.4.5.3.1 U.A.E Drugs For Schistosomiasis Market by Site
9.4.5.3.2 U.A.E Drugs For Schistosomiasis Market by Drug Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Drugs For Schistosomiasis Market Overview
9.5.2 South and Central America Drugs For Schistosomiasis Market Forecasts and Analysis
9.5.3 South and Central America Drugs For Schistosomiasis Market Forecasts and Analysis - By Site
9.5.4 South and Central America Drugs For Schistosomiasis Market Forecasts and Analysis - By Drug Type
9.5.5 South and Central America Drugs For Schistosomiasis Market Forecasts and Analysis - By Countries
9.5.5.1 Argentina Drugs For Schistosomiasis Market
9.5.5.1.1 Argentina Drugs For Schistosomiasis Market by Site
9.5.5.1.2 Argentina Drugs For Schistosomiasis Market by Drug Type
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DRUGS FOR SCHISTOSOMIASIS MARKET, KEY COMPANY PROFILES
11.1. SHIN POONG PHARMA.CO., LTD.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MERCK AND CO., INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BAYER AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Shin Poong Pharma.Co., Ltd.
2. Merck & Co., Inc.
3. Bayer AG

TIPRE00008459
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking